文献速递产科母胎医学

胎儿生物物理评分在胎儿生长受限管理中的作用

The role of the fetal biophysical profile in the management of fetal growth restriction.
PubMed 文献 · Am J Obstet Gynecol · 2022-01-01

本综述阐述胎儿生物物理评分在胎儿生长受限监测中的作用。从妊娠中期起,生物物理评分与当前胎儿pH的符合度超过90%,正常评分预测pH>7.25的阳性预测值为100%,异常评分则以相似确定性预测当前胎儿酸血症。综述旨在为胎儿生长受限的门诊与住院管理中的生物物理评分提供指导。

要点

  • 生物物理评分与当前胎儿pH符合度超过90%,正常评分预测pH>7.25的阳性预测值为100%。
  • 30%至70%的生长受限胎儿心率无反应需生物物理评分核实胎儿健康,其中8%至27%评分异常提示需分娩。
  • 生物物理评分不能预测未来胎儿健康,需结合脐动脉多普勒与羊水量确定监测频率。

核心结论

  • 胎儿生长受限管理需综合评估当前胎儿健康、分娩后新生儿风险与预计胎儿恶化速度。
  • 生物物理评分可准确反映当前胎儿酸碱状态,但不能预测未来胎儿健康。
  • 将生物物理评分整合入胎儿生长受限监测可更好应对不同孕周的临床管理挑战。

研究设计与样本

  • 本文为综述,旨在为胎儿生长受限门诊与住院管理中的生物物理评分提供指导。

主要发现

  • 从妊娠中期起,生物物理评分与当前胎儿pH的符合度超过90%。
  • 正常评分预测pH>7.25的阳性预测值为100%;异常评分以相似确定性预测当前胎儿酸血症。
  • 30%至70%心率无反应的生长受限胎儿需生物物理评分核实胎儿健康,其中8%至27%评分异常提示需分娩,且多普勒未提示该需求。
  • 生物物理评分不预测未来胎儿健康,故需脐动脉多普勒与羊水量确定监测频率。
  • 整合频繁心率监测、生物物理评分与多普勒的监测策略报告更好结局,死产率0%至4%,而经验性确定监测频率者为8%至11%。

关键数值与推荐

  • 生物物理评分与当前胎儿pH符合度超过90%。
  • 正常评分预测pH>7.25的阳性预测值为100%。
  • 心率无反应的生长受限胎儿中30%至70%需生物物理评分,其中8%至27%评分异常提示需分娩。
  • 整合监测策略下死产率为0%至4%,经验性监测频率下为8%至11%。

临床怎么用

  • 综述旨在为胎儿生长受限门诊与住院管理中的生物物理评分提供指导。
  • 生物物理评分用于核实当前胎儿健康并辅助确定分娩阈值。
  • 监测频率应结合脐动脉多普勒与羊水量确定,而非仅依据生物物理评分。

局限性

  • 生物物理评分不能预测未来胎儿健康。
  • 综述未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Growth-restricted fetuses are at risk of hypoxemia, acidemia, and stillbirth because of progressive placental dysfunction. Current fetal well-being, neonatal risks following delivery, and the anticipated rate of fetal deterioration are the major management considerations in fetal growth restriction. Surveillance has to quantify the fetal risks accurately to determine the delivery threshold and identify the testing frequency most likely to capture future deterioration and prevent stillbirth. From the second trimester onward, the biophysical profile score correlates over 90% with the current fetal pH, and a normal score predicts a pH >7.25 with a 100% positive predictive value; an abnormal score on the other hand predicts current fetal acidemia with similar certainty. Between 30% and 70% of growth-restricted fetuses with a nonreactive heart rate require biophysical profile scoring to verify fetal well-being, and an abnormal score in 8% to 27% identifies the need for delivery, which is not suspected by Doppler findings. Future fetal well-being is not predicted by the biophysical profile score, which emphasizes the importance of umbilical artery Doppler and amniotic fluid volume to determine surveillance frequency. Studies with integrated surveillance strategies that combine frequent heart rate monitoring with biophysical profile scoring and Doppler report better outcomes and stillbirth rates of between 0% and 4%, compared with those between 8% and 11% with empirically determined surveillance frequency. The variations in clinical behavior and management challenges across gestational age are better addressed when biophysical profile scoring is integrated into the surveillance of fetal growth restriction. This review aims to provide guidance on biophysical profile scoring in the in- and outpatient management of fetal growth restriction.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Baschat AA, Galan HL, Lee W, et al. The role of the fetal biophysical profile in the management of fetal growth restriction. Am J Obstet Gynecol. 2022. PMID: 35369904. doi:10.1016/j.ajog.2022.01.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。